Low price ! Pramipexole Dihydrochloride Monohydrate CAS NO.191217-81-9

quantitative dilution in each 1 ml contains about 10 mg
The solution, determined in accordance with the law. Than the curl should be 67.0 ° and 69.5 ° (with no water content).
[identify] (1) in the content determination of record chromatograph chart, the main peak of retention time of test sample solution should be consistent with the main peak retention time of the reference substance solution.
(2) the infrared absorption spectrum of the product shall be consistent with the reference substance of the map
(3) identification of the product show chloride aqueous solution reaction

Beijing HuaRui joint biomedical technology co., LTD. Is a special material research and development, production, sales and medicine and new product development, technical services as the core business of high-tech enterprises, the company is located in Beijing economic and technological development zone.
Company's main business includes: active pharmaceutical ingredients, pharmaceutical intermediates, development, production and sales; The impurity control product development and sales; Chemical generic drugs and new drug development technology services; New drug project registration service at home and abroad.
The product (S) - 2 - amino - 4, 7-4-6 - hydrogen (normal propyl amino) benzothiazole hydrochloride monohydrate, calculated on anhydride, including C10H19Cl2N3S not less than 99.0%.
Description: white or white crystalline powder; Have led to wet.
Moisture: 5.0% ~ 7.0%.
Antipsychotic drugs; Treatment of signs and symptoms of idiopathic Parkinson's disease, (no levodopa) alone or in combination with levodopa. Late in the disease, for example, the curative effect of levodopa waning or change and fluctuate phenomenon or "switch" at the end of the volatility (agent), need to apply this product.